Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Pharming Group NV (PHAR)
Pharming Group NV (PHAR) News

PHAR

Pharming Group NV (PHAR)

Pharming Group NV

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PHAR

1 2 3 4 5 6 Next >>

Date	Time	Source	Headline	Symbol	Company
05/30/2024	5:19PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHAR	Pharming Group NV
05/21/2024	1:54PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHAR	Pharming Group NV
05/15/2024	11:52AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHAR	Pharming Group NV
05/08/2024	6:04AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHAR	Pharming Group NV
01/08/2024	9:17AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHAR	Pharming Group NV
10/26/2023	9:25AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHAR	Pharming Group NV
08/24/2023	2:00AM	PR Newswire (US)	Pharming Group to participate in September investor conferences	NASDAQ:PHAR	Pharming Group NV
08/14/2023	1:00AM	PR Newswire (US)	Pharming Group to convene Extraordinary General Meeting of Shareholders	NASDAQ:PHAR	Pharming Group NV
08/09/2023	1:00AM	PR Newswire (US)	Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan	NASDAQ:PHAR	Pharming Group NV
08/09/2023	1:00AM	PR Newswire (US)	Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan	NASDAQ:PHAR	Pharming Group NV
08/03/2023	11:09AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHAR	Pharming Group NV
08/03/2023	1:00AM	PR Newswire (US)	Pharming Group reports second quarter and first half 2023 financial results	NASDAQ:PHAR	Pharming Group NV
07/18/2023	1:00AM	PR Newswire (US)	Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board	NASDAQ:PHAR	Pharming Group NV
07/18/2023	1:00AM	PR Newswire (US)	Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board	NASDAQ:PHAR	Pharming Group NV
07/13/2023	2:00AM	PR Newswire (US)	Pharming Group to report second quarter and first half 2023 financial results on August 3	NASDAQ:PHAR	Pharming Group NV
07/13/2023	2:00AM	PR Newswire (US)	Pharming Group to report second quarter and first half 2023 financial results on August 3	NASDAQ:PHAR	Pharming Group NV
06/01/2023	6:15AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:PHAR	Pharming Group NV
06/01/2023	1:00AM	PR Newswire (US)	Pharming announces sale of priority review voucher	NASDAQ:PHAR	Pharming Group NV
06/01/2023	1:00AM	PR Newswire (US)	Pharming announces sale of priority review voucher	NASDAQ:PHAR	Pharming Group NV
05/25/2023	2:00AM	PR Newswire (US)	Pharming Group to attend the following Investor Conferences in June	NASDAQ:PHAR	Pharming Group NV
05/25/2023	2:00AM	PR Newswire (US)	Pharming Group to attend the following Investor Conferences in June	NASDAQ:PHAR	Pharming Group NV
05/17/2023	11:28AM	PR Newswire (US)	Pharming Group reports on results of the 2023 Annual General Meeting of Shareholders	NASDAQ:PHAR	Pharming Group NV
05/11/2023	1:00AM	PR Newswire (US)	Pharming Group reports financial results for the first quarter of 2023	NASDAQ:PHAR	Pharming Group NV
05/11/2023	1:00AM	PR Newswire (US)	Pharming Group reports financial results for the first quarter of 2023	NASDAQ:PHAR	Pharming Group NV
04/26/2023	2:00AM	PR Newswire (US)	Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023	NASDAQ:PHAR	Pharming Group NV
04/19/2023	2:00AM	PR Newswire (US)	Pharming to attend the Van Lanschot Kempen Life Sciences Conference 2023	NASDAQ:PHAR	Pharming Group NV
04/19/2023	1:36AM	PR Newswire (US)	Notice of First Quarter 2023 Results	NASDAQ:PHAR	Pharming Group NV
04/13/2023	7:11AM	PR Newswire (US)	Pharming to present at the 22nd Annual Needham Virtual Healthcare Conference 2023	NASDAQ:PHAR	Pharming Group NV
04/11/2023	8:58AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:PHAR	Pharming Group NV
04/11/2023	1:00AM	PR Newswire (US)	Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.	NASDAQ:PHAR	Pharming Group NV

Showing the most relevant articles for your search:NASDAQ:PHAR

1 2 3 4 5 6 Next >>

Anavex Life Sciences

Global Developments (PK)

Asia Broadband (PK)

GNCC Capital (CE)

Digital Brand Media and ... (PK)

Accredited Solutions (PK)

Quantum Computing

Super Micro Computer

Clean Vision (QB)

Code Green Apparel (PK)

Halozyme Therapeutics

Net Savings Link (PK)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions